+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Competitive interaction between chronic obstructive pulmonary disease and CHA 2 DS 2 -VASc score in predicting incident atrial fibrillation

Competitive interaction between chronic obstructive pulmonary disease and CHA 2 DS 2 -VASc score in predicting incident atrial fibrillation

International Journal of Cardiology 255: 74-79

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality, and an emerging risk factor for atrial fibrillation (AF). CHADS2 and CHA2DS2-VASc scores are significantly associated with incident AF independently of other risk factors. The aim of this study was to demonstrate a possible interaction between COPD and CHA2DS2-VASc in predicting incident AF. This observational prospective cohort study included 4322 Caucasians with cardiovascular risk factors, stratified by CHA2DS2-VASc score (>2 vs <2) and presence/absence of COPD. To detect AF appearance, patients underwent, every 6months, physical examination, standard 12‑lead electrocardiogram and routine laboratory tests. COPD prevalence was significantly higher in patients with CHA2DS2-VASc≥2 vs CHA2DS2-VASc<2 category (13.3% vs 10.5%, P=0.009). During the follow-up, 589 cases of AF were documented (3.8 events/100 patients-year). COPD+ showed a significantly higher incidence of AF vs COPD- patients (17.4 vs 8.4 events/100 patients-year, P<0.0001). In Cox regression models both CHA2DS2-VASc score (HR=4.70, 95% CI=3.63-6.08) and COPD (HR=2.04, 95% CI=1.69-2.48) significantly predicted the incidence rate of AF; this was also confirmed introducing the two variables into the same Cox model. A significant competitive interaction between CHA2DS2-VASc and COPD was found in a Cox model in patients with CHA2DS2-VASc<2 (HR=8.45, 95% CI=5.20-13.74) than in those with CHA2DS2-VASc≥2. COPD is an independent and strong predictor of incident AF. The presence of COPD increases the HR for incident AF about five times in patients with CHA2DS2VASc score<2, while the coexistence of a CHA2DS2Vasc score≥2 minimizes the prognostic significance of COPD.

(PDF emailed within 0-6 h: $19.90)

Accession: 055579824

Download citation: RISBibTeXText

PMID: 29174184

DOI: 10.1016/j.ijcard.2017.11.036

Related references

CHA 2 DS 2 -VASc: An eligible score for atrial fibrillation prediction in chronic obstructive pulmonary disease?. International Journal of Cardiology 257: 299, 2018

Use of CHA 2 DS 2 -VASc Score to Predict New-Onset Atrial Fibrillation in Chronic Obstructive Pulmonary Disease Patients - Large-Scale Longitudinal Study. Circulation Journal 81(12): 1792-1797, 2017

CHA2DS2-VASc score for ischaemic stroke risk stratification in patients with chronic obstructive pulmonary disease with and without atrial fibrillation: a nationwide cohort study. Europace 20(4): 575-581, 2017

Value of the CHA 2 DS 2 -VASc score and Fabry-specific score for predicting new-onset or recurrent stroke/TIA in Fabry disease patients without atrial fibrillation. Clinical Research in Cardiology 107(12): 1111-1121, 2018

Dyspnea, Eosinopenia, Consolidation, Acidemia and Atrial Fibrillation Score and BAP-65 Score, Tools for Prediction of Mortality in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Comparative Pilot Study. Indian Journal of Critical Care Medicine 21(10): 671-677, 2017

Does CHA2DS2-VASc score predict ischaemic stroke in chronic obstructive pulmonary disease?. Europace 20(4): 729, 2017

The ABC-stroke risk score was superior to the CHA2DS2-VASc score for predicting stroke in atrial fibrillation. Annals of Internal Medicine 164(12): Jc69, 2017

Which components of the CHA2DS2-VASc score are the most important in obstructive sleep apnea patients with atrial fibrillation?. Blood Coagulation and Fibrinolysis 27(3): 347-351, 2016

Clinical characteristics and prognostic significance of chronic obstructive pulmonary disease in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry study. Journal of the American Medical Directors Association 15(8): 576-581, 2015

Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry. American Heart Journal 181(): 83-91, 2016

Performance of the CHA2DS2-VASc score in predicting new onset atrial fibrillation during hospitalization for community-acquired pneumonia. European Journal of Internal Medicine 2019, 2019

Correlation of chronic obstructive pulmonary disease assessment test and clinical chronic obstructive pulmonary disease questionnaire score with BODE index in patients of stable chronic obstructive pulmonary disease. Lung India 35(6): 494-498, 2018

Prognostic value of CHA2DS2-VASc score in patients with 'non-valvular atrial fibrillation' and valvular heart disease: the Loire Valley Atrial Fibrillation Project. European Heart Journal 36(28): 1822-1830, 2016

CHA2DS2-VASc score is a useful-predictor of not prognosis but coronary-arteriosclerosis in chronic atrial-fibrillation compared with CHADS2 score: a two-center study of 320-slice CT, part 2. International Journal of Cardiology 177(2): 368-373, 2015

CHA2DS2-VASc score is useful in predicting poor 12-month outcomes following myocardial infarction in diabetic patients without atrial fibrillation. Acta Diabetologica 53(5): 807-815, 2017